Calcium in PDB 8e5a: Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution

The binding sites of Calcium atom in the Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution (pdb code 8e5a). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 2 binding sites of Calcium where determined in the Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution, PDB code: 8e5a:
Jump to Calcium binding site number: 1; 2;

Calcium binding site 1 out of 2 in the Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution within 5.0Å range: probe atom residue distance (Å) B Occ A:Ca2201 b:25.7 occ:1.00 OE2 A:GLU364 2.4 25.2 1.0 OE1 A:GLU1101 2.5 24.4 1.0 OE1 A:GLU705 2.7 22.4 1.0 OE2 A:GLU1101 2.8 24.4 1.0 CD A:GLU1101 3.0 24.4 1.0 CD A:GLU364 3.2 25.2 1.0 OE1 A:GLU364 3.5 25.2 1.0 O A:GLY1405 3.5 27.4 1.0 O A:GLU1406 3.6 25.8 1.0 CD A:GLU705 3.7 22.4 1.0 OE2 A:GLU705 4.0 22.4 1.0 CA A:GLU1406 4.4 25.8 1.0 CG A:GLU364 4.4 25.2 1.0 C A:GLU1406 4.4 25.8 1.0 CG A:GLU1101 4.5 24.4 1.0 O A:MET363 4.6 24.1 1.0 C A:GLY1405 4.6 27.4 1.0 OE2 A:GLU1406 4.7 25.8 1.0 CD A:GLU1406 4.8 25.8 1.0 CA A:GLU705 4.9 22.4 1.0 O A:PHE1100 4.9 18.0 1.0 OE1 A:GLU1406 5.0 25.8 1.0

Calcium binding site 2 out of 2 in the Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Human L-Type Voltage-Gated Calcium Channel CAV1.3 Treated with 1.4 Mm Sofosbuvir at 3.3 Angstrom Resolution within 5.0Å range: probe atom residue distance (Å) B Occ D:Ca1203 b:24.8 occ:1.00 OG D:SER263 2.4 16.3 1.0 OG1 D:THR331 2.4 25.9 1.0 OG D:SER261 2.9 20.1 1.0 OD2 A:ASP153 3.0 21.7 1.0 CB D:SER263 3.7 16.3 1.0 CB D:THR331 3.7 25.9 1.0 CB D:SER261 3.9 20.1 1.0 OD2 D:ASP259 4.0 22.8 1.0 CG A:ASP153 4.0 21.7 1.0 CG2 D:THR331 4.2 25.9 1.0 OD1 D:ASP363 4.2 31.3 1.0 OD1 A:ASP153 4.3 21.7 1.0 N D:SER263 4.5 16.3 1.0 O D:GLY364 4.6 29.1 1.0 OD2 D:ASP363 4.6 31.3 1.0 CA D:SER263 4.7 16.3 1.0 OD1 D:ASP259 4.8 22.8 1.0 CG D:ASP259 4.8 22.8 1.0 CA D:THR331 4.9 25.9 1.0 CG D:ASP363 4.9 31.3 1.0

X.Yao, S.Gao, J.Wang, Z.Li, J.Huang, Y.Wang, Z.Wang, J.Chen, X.Fan, W.Wang, X.Jin, X.Pan, Y.Yu, A.Lagrutta, N.Yan. Structural Basis For the Severe Adverse Interaction of Sofosbuvir and Amiodarone on L-Type Ca V Channels. Cell V. 185 4801 2022.
ISSN: ISSN 1097-4172
PubMed: 36417914
DOI: 10.1016/J.CELL.2022.10.024